CHICAGO TRUST Co NA Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

CHICAGO TRUST Co NA reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.7% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,923 shares of the healthcare conglomerate’s stock after selling 586 shares during the quarter. UnitedHealth Group comprises approximately 1.2% of CHICAGO TRUST Co NA’s holdings, making the stock its 14th largest position. CHICAGO TRUST Co NA’s holdings in UnitedHealth Group were worth $6,072,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Vanguard Group Inc. raised its holdings in UnitedHealth Group by 0.6% in the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after buying an additional 544,740 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of UnitedHealth Group by 0.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after purchasing an additional 94,641 shares in the last quarter. Capital Research Global Investors increased its holdings in UnitedHealth Group by 2.2% in the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after buying an additional 324,733 shares in the last quarter. Capital International Investors lifted its stake in UnitedHealth Group by 4.8% during the 4th quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after acquiring an additional 542,424 shares during the period. Finally, Norges Bank purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $5,802,231,000. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Barclays lifted their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Truist Financial increased their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Piper Sandler lifted their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Two equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $614.17.

UnitedHealth Group Stock Down 1.3 %

NYSE UNH traded down $7.48 during trading on Friday, reaching $558.76. 2,964,027 shares of the company’s stock traded hands, compared to its average volume of 4,283,194. The company’s 50 day simple moving average is $521.83 and its two-hundred day simple moving average is $505.02. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $591.54. The firm has a market cap of $514.28 billion, a price-to-earnings ratio of 34.15, a price-to-earnings-growth ratio of 1.58 and a beta of 0.59. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. UnitedHealth Group’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.14 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.50%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.